← Leaderboards
Joanna Hellmuth
University Of California, San Francisco
$795,528
Attributed
$795,528
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $198.9K · FY2017–20$200K$150K$100K$50K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$795,528 · 1
By mechanism
K23$795,528 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Bruce L Miller$34,542,477
- Lishomwa C Ndhlovu$30,426,942
- Katherine Laurel Possin$34,925,765
- Hideho Okada$20,052,698
- Adithya Cattamanchi$24,815,234
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCohortCerebral AtrophyAmyloidBrain ScanAntiretroviral TherapyAtrophicBaseBehavioral NeurologyBiological MarkersCognitiveCaliforniaCaringCerebellumAgingCerebrospinal FluidCharacteristicsClinicClinical CareClinically RelevantClinical ResearchCognition DisordersAccurate DiagnosisCost
Grant awards (4)
Defining the clinical utility of CSF biomarkers of neurodegeneration in HIV+ elders$198,882
K23 · FY2020 · MH · contact PI
Defining the clinical utility of CSF biomarkers of neurodegeneration in HIV+ elders$198,882
K23 · FY2019 · MH · contact PI
Defining the clinical utility of CSF biomarkers of neurodegeneration in HIV+ elders$198,882
K23 · FY2018 · MH · contact PI
Defining the clinical utility of CSF biomarkers of neurodegeneration in HIV+ elders$198,882
K23 · FY2017 · MH · contact PI